• Acetylcholine Chloride: Advancing Gut-Brain Axis Research

  2026-06-19

  This thought-leadership article provides translational researchers with mechanistic insights and strategic guidance for leveraging Acetylcholine Chloride in gut-brain axis research, highlighting new discoveries in epilepsy, protocol parameters, and future directions for microbiota-targeted therapies.

• Streptavidin – Cy5: Mechanistic Precision in Biotin Detectio

  2026-06-19

  Explore how Streptavidin – Cy5’s Cy5 fluorescent dye enables unparalleled specificity in biotin detection assays. This article uniquely dissects its mechanistic advantages and practical implications for apoptosis research and advanced immunofluorescence workflows.

• EdU Flow Cytometry Assay Kits (Cy5): Enabling Precision Cell

  2026-06-18

  Explore how EdU Flow Cytometry Assay Kits (Cy5) empower advanced, denaturation-free DNA synthesis detection for cell proliferation studies. This article reveals distinct insights into DCPS biomarker relevance and practical assay optimization, setting it apart from prior content.

• AM 281: Precision CB1 Cannabinoid Receptor Antagonist Workfl

  2026-06-18

  AM 281, supplied by APExBIO, sets a benchmark for selective CB1 cannabinoid receptor antagonism in neuropharmacology research. This guide translates recent reference-driven insights, including modulation of the CB1-CREB-GLT-1 pathway in traumatic brain injury, into stepwise protocols and troubleshooting strategies for rigorous memory and cognitive dysfunction studies.

• A-769662: Precision AMPK Activator for Energy Metabolism Stu

  2026-06-17

  A-769662 stands out as a potent and selective AMPK activator, enabling reproducible metabolic assays and mechanistic studies across cell and animal models. Recent insights into AMPK signaling and autophagy reshuffle protocol design, making APExBIO’s A-769662 vital for next-generation metabolism and diabetes research.

• LY2886721: BACE Inhibitor-Driven Amyloid Beta Reduction Prot

  2026-06-17

  LY2886721 sets a new standard for Alzheimer’s disease research by enabling precise, nanomolar-range BACE1 inhibition with a proven synaptic safety profile. This guide translates recent experimental breakthroughs and troubleshooting strategies into actionable protocols for robust amyloid beta modulation.

• Capsazepine (SKU A3279): Reliable TRPV1 Antagonist for Pain

  2026-06-16

  This article addresses common laboratory challenges in pain and apoptosis research, focusing on how Capsazepine (SKU A3279) from APExBIO delivers reproducible, data-driven solutions. By analyzing real-world scenarios, it helps biomedical scientists optimize protocols, interpret results, and select reliable TRPV1 ion channel antagonists for cell-based assays.

• BCECF: Precision pH Sensing for Biomedical and Ion Transport

  2026-06-16

  BCECF (2',7'-bis(carboxyethyl)-5(6)-Carboxyfluorescein) is a ratiometric, pH-sensitive fluorescent probe with high selectivity for extracellular and compartmental pH measurement. Its dual-excitation properties enable quantitative analysis of acid-base homeostasis and microenvironmental pH regulation. This dossier details BCECF’s mechanism, validated applications, and integration protocols for ion transport and metabolism research.

• SIRT1 Activation Restores Mitochondrial Function in Prion Mo

  2026-06-15

  This study demonstrates that SIRT1 activation, particularly via resveratrol, reverses mitochondrial dysfunction and apoptosis in N2a neuroblastoma cells exposed to prion protein fragment PrP106–126. The work elucidates the PGC-1α/TFAM pathway as a mechanism for SIRT1-mediated mitochondrial biogenesis, suggesting new avenues for neuroprotection in prion diseases.

• Irinotecan (CPT-11): Quantitative Benchmarks and Translation

  2026-06-15

  Explore Irinotecan (CPT-11) as a topoisomerase I inhibitor with a focus on quantitative cytotoxicity benchmarks, practical protocol pitfalls, and translational boundaries in colorectal cancer research. This article delivers new clarity on data interpretation, dosing, and experimental reproducibility.

• Everolimus (RAD001) Workflows: Precision mTOR Inhibition in

  2026-06-14

  Everolimus (RAD001) redefines mTOR inhibition workflows, enabling precise control of cancer cell proliferation and apoptosis in both in vitro and in vivo models. This guide distills actionable protocols, innovative assay design, and troubleshooting insights for high-impact cancer research, leveraging APExBIO’s trusted purity and quality.

• 3-Deazaadenosine: Epigenetic Disruption for Translational Im

  2026-06-13

  Explore how 3-Deazaadenosine, a potent S-adenosylhomocysteine hydrolase inhibitor, is redefining mechanistic research and translational strategy in inflammation and infectious disease. This article bridges epigenetic methylation, preclinical antiviral research, and the expanding therapeutic frontier, offering actionable guidance for the next generation of translational scientists.

• RAS/PI3K Mutations Sensitize Ovarian Cancer to PARP/NAMPT In

  2026-06-12

  This study demonstrates that epithelial ovarian cancer cells with RAS/PI3K pathway mutations are selectively vulnerable to a combination of PARP and NAMPT inhibition. The findings highlight the metabolic dependence of these cells and provide a rationale for biomarker-driven combination therapies to overcome PARP inhibitor resistance.

• EZ Cap™ Mouse IL-12 mRNA (m1Ψ): Redefining Cytokine mRNA for

  2026-06-12

  Explore how EZ Cap™ Mouse IL-12 mRNA (m1Ψ) advances immunotherapy research with optimized stability, low immunogenicity, and enhanced cytokine expression. Go beyond delivery platforms to understand the molecular and experimental advantages that set this mRNA product apart.

• Entecavir (BMS200475): Resistance, Clinical Outcomes, and Re

  2026-06-11

  Explore Entecavir as a potent HBV DNA polymerase inhibitor, with a focus on resistance, long-term clinical outcomes, and decision-making for advanced chronic hepatitis B infection therapy. This article provides unique insight into comparative efficacy and the practical implications for translational research.

451 records 14/31 page Previous Next First page 上5页 1112131415 下5页 Last page